{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:44:06Z","timestamp":1790786646387,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014039","name":"DOD Prostate Cancer Research Program","doi-asserted-by":"publisher","award":["W81XWH-21-1-0640"],"award-info":[{"award-number":["W81XWH-21-1-0640"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014039","name":"DOD Prostate Cancer Research Program","doi-asserted-by":"publisher","award":["R01CA218545"],"award-info":[{"award-number":["R01CA218545"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014039","name":"DOD Prostate Cancer Research Program","doi-asserted-by":"publisher","award":["R01CA241752"],"award-info":[{"award-number":["R01CA241752"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijbiomac.2024.136921","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T07:16:19Z","timestamp":1730099779000},"page":"136921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P3","title":["Clofazimine inhibits small-cell lung cancer progression by modulating the kynurenine\/aryl hydrocarbon receptor axis"],"prefix":"10.1016","volume":"282","author":[{"given":"Gunjan","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan Abul","family":"Qais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvez","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse L.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarique","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Wasim","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawed A.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136921_bb0015","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.ejca.2011.12.002","article-title":"Effect of cigarette smoking on quality of life in small cell lung cancer patients","volume":"48","author":"Chen","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0020","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1038\/s41467-023-41585-z","article-title":"YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136921_bb0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00432-024-05621-9","article-title":"Prognostic factors in extensive-stage small cell lung cancer patients with organ-specific metastasis: unveiling commonalities and disparities","volume":"150","author":"Wu","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0030","doi-asserted-by":"crossref","first-page":"38012","DOI":"10.1038\/srep38012","article-title":"Association between dioxin and cancer incidence and mortality: a meta-analysis","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0035","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8371","article-title":"The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the transcriptome of aryl hydrocarbon receptor (AhR) knock-down porcine granulosa cells","volume":"8","author":"Ruszkowska","year":"2020","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010387","article-title":"How the AHR became important in Cancer: the role of chronically active AHR in Cancer aggression","volume":"22","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136921_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108303","article-title":"Aryl hydrocarbon receptor is a tumor promoter in MYCN-amplified neuroblastoma cells through suppression of differentiation","volume":"26","author":"Chaudhry","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1479-5876-9-2","article-title":"Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6\/E7 oncoproteins","volume":"9","author":"Buonomo","year":"2011","journal-title":"J. Transl. Med."},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.136921_bb0055","doi-asserted-by":"crossref","first-page":"18691","DOI":"10.1002\/cam4.6484","article-title":"The tryptophan-kynurenine pathway in immunomodulation and cancer metastasis","volume":"12","author":"Basson","year":"2023","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The therapeutic potential of targeting tryptophan catabolism in cancer","volume":"122","author":"Opitz","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0065","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1038\/s41598-023-30841-3","article-title":"Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples","volume":"13","author":"Dutta","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0070","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013122","article-title":"Mechanisms of small cell lung cancer metastasis","volume":"13","author":"Ko","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136921_bb0075","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1530\/JME-22-0076","article-title":"Aryl hydrocarbon receptor (AhR)-mediated signaling as a critical regulator of skeletal cell biology","volume":"69","author":"Alhamad","year":"2022","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0080","doi-asserted-by":"crossref","first-page":"1097897","DOI":"10.3389\/fonc.2023.1097897","article-title":"Deep learning of bone metastasis in small cell lung cancer: a large sample-based study","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136921_bb0085","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1172\/JCI70712","article-title":"Inhibition of the aryl hydrocarbon receptor\/polyamine biosynthesis axis suppresses multiple myeloma","volume":"128","author":"Bianchi-Smiraglia","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115539","article-title":"Clofazimine: a journey of a drug","volume":"167","author":"Xu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136921_bb0095","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bcp.2013.12.007","article-title":"Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling","volume":"87","author":"Koval","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0100","doi-asserted-by":"crossref","unstructured":"C. Kosianova capital A, O. Pak, I. Bryukhovetskiy, Regulation of cancer stem cells and immunotherapy of glioblastoma (review), Biomed. Rep. 20(2) (2024) 24.","DOI":"10.3892\/br.2023.1712"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136921_bb0105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3324\/haematol.2018.194910","article-title":"Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-gamma and synergizes with imatinib to inhibit chronic myeloid leukemia cells","volume":"105","author":"Kumar","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136921_bb0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1034\/j.1601-0825.2002.01829.x","article-title":"Regulatory mechanisms of osteoblast and osteoclast differentiation","volume":"8","author":"Katagiri","year":"2002","journal-title":"Oral Dis."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136921_bb0115","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/jcb.20284","article-title":"Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells","volume":"93","author":"Boland","year":"2004","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41413-021-00178-6","article-title":"GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation","volume":"10","author":"Siddiqui","year":"2022","journal-title":"Bone Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136921_bb0125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.136921_bb0130","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2024.136921_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","article-title":"GROMACS: a message-passing parallel molecular dynamics implementation","volume":"91","author":"Berendsen","year":"1995","journal-title":"Comput. Phys. Commun."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.136921_bb0140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1756-0500-5-367","article-title":"ACPYPE - AnteChamber PYthon parser interfacE","volume":"5","author":"Sousa da Silva","year":"2012","journal-title":"BMC. Res. Notes"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0150","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.136921_bb0155","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.136921_bb0160","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-022-01695-6","article-title":"MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4\/FOXM1\/RRM2 axis","volume":"22","author":"Khan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115762","article-title":"Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-beta signaling","volume":"143","author":"Siddiqui","year":"2021","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0175","doi-asserted-by":"crossref","first-page":"15300","DOI":"10.1038\/s41598-017-15563-7","article-title":"Catabolic effects of human PTH (1-34) on bone: requirement of monocyte chemoattractant Protein-1 in murine model of hyperparathyroidism","volume":"7","author":"Siddiqui","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0180","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.biopha.2017.01.044","article-title":"p53 dependent apoptosis and cell cycle delay induced by heteroleptic complexes in human cervical cancer cells","volume":"88","author":"Sharma","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0185","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1038\/s41598-024-54479-x","article-title":"Alpha-lipoic acid modulates prostate cancer cell growth and bone cell differentiation","volume":"14","author":"Abdullah","year":"2024","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136921_bb0190","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41419-018-1091-y","article-title":"miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer","volume":"9","author":"Kong","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jinorgbio.2017.05.013","article-title":"Unfolding biological properties of a versatile dicopper(II) precursor and its two mononuclear copper(II) derivatives","volume":"174","author":"Paul","year":"2017","journal-title":"J. Inorg. Biochem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136921_bb0200","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.18632\/aging.203935","article-title":"Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer","volume":"14","author":"Pothuraju","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136921_bb0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41388-022-02587-1","article-title":"Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis","volume":"42","author":"Bhatia","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0210","article-title":"Hydroxychloroquine interaction with phosphoinositide 3-kinase modulates prostate cancer growth in bone microenvironment: in vitro and molecular dynamics based approach","volume":"130912","author":"Abdullah","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.136921_bb0215","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41388-023-02929-7","article-title":"Genetically-engineered mouse models of small cell lung cancer: the next generation","volume":"43","author":"Oser","year":"2024","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136921_bb0220","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.taap.2014.08.025","article-title":"The aryl hydrocarbon receptor suppresses osteoblast proliferation and differentiation through the activation of the ERK signaling pathway","volume":"280","author":"Yu","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0225","first-page":"321","article-title":"Bone Metastases: An Overview","volume":"11","author":"Macedo","year":"2017","journal-title":"Oncol. Rev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136921_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112944","article-title":"Mechanisms, diagnosis and treatment of bone metastases","volume":"10","author":"Ban","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136921_bb0235","first-page":"763","article-title":"Targeted therapy vs chemotherapy: which has had more impact on survival in lung cancer? Does targeted therapy make patients live longer? Hard to prove, but impossible to ignore","volume":"12","author":"Camidge","year":"2014","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.136921_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26134100","article-title":"Pongrakhananon, targeting the PI3K\/AKT\/mTOR signaling pathway in lung Cancer: an update regarding potential drugs and natural products","volume":"26","author":"Iksen","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136921_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082201","article-title":"High-risk human papillomavirus and tobacco smoke interactions in epithelial carcinogenesis","volume":"12","author":"Aguayo","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.136921_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217946","article-title":"Effect of tryptophan-derived AhR ligands, kynurenine, Kynurenic acid and FICZ, on proliferation, cell cycle regulation and cell death of melanoma cells-in vitro studies","volume":"21","author":"Walczak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"31","key":"10.1016\/j.ijbiomac.2024.136921_bb0255","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136921_bb0260","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1734-1140(12)70870-8","article-title":"Kynurenic acid enhances expression of p21 Waf1\/Cip1 in colon cancer HT-29 cells","volume":"64","author":"Walczak","year":"2012","journal-title":"Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.136921_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25071655","article-title":"A tryptophan metabolite, 8-Hydroxyquinaldic acid, exerts Antiproliferative and anti-migratory effects on colorectal Cancer cells","volume":"25","author":"Walczak","year":"2020","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136921_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011017","article-title":"Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling","volume":"19","author":"Li","year":"2023","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136921_bb0275","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1039\/D1MD00015B","article-title":"Recent advances in the development of AHR antagonists in immuno-oncology","volume":"12","author":"Sun","year":"2021","journal-title":"RSC Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136921_bb0280","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.115.064246","article-title":"Indole and tryptophan metabolism: endogenous and dietary routes to ah receptor activation","volume":"43","author":"Hubbard","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0285","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1038\/s41467-022-34773-w","article-title":"Cryo-EM structure of the agonist-bound Hsp90-XAP2-AHR cytosolic complex","volume":"13","author":"Gruszczyk","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0290","doi-asserted-by":"crossref","DOI":"10.1177\/11786469231185102","article-title":"The role of the kynurenine\/AhR pathway in diseases related to metabolism and Cancer","volume":"16","author":"Shadboorestan","year":"2023","journal-title":"Int. J. Tryptophan Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0295","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cas.15182","article-title":"Stemness and immune evasion conferred by the TDO2-AHR pathway are associated with liver metastasis of colon cancer","volume":"113","author":"Miyazaki","year":"2022","journal-title":"Cancer Sci."},{"issue":"14 Suppl","key":"10.1016\/j.ijbiomac.2024.136921_bb0300","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.2527\/jas.2007-0567","article-title":"The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth","volume":"86","author":"Yang","year":"2008","journal-title":"J. Anim. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0305","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/s41467-022-29098-7","article-title":"Cell-intrinsic aryl hydrocarbon receptor signalling is required for the resolution of injury-induced colonic stem cells","volume":"13","author":"Shah","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.136921_bb0310","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1021\/acsptsci.2c00253","article-title":"Induction of aryl hydrocarbon receptor-mediated Cancer cell-selective apoptosis in triple-negative breast Cancer cells by a high-affinity Benzimidazoisoquinoline","volume":"6","author":"Elson","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0315","doi-asserted-by":"crossref","first-page":"23189","DOI":"10.1038\/s41598-021-02339-3","article-title":"Endogenous regulation of the Akt pathway by the aryl hydrocarbon receptor (AhR) in lung fibroblasts","volume":"11","author":"Shi","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136921_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28103978","article-title":"Aryl hydrocarbon receptor as an anticancer target: an overview of ten years odyssey","volume":"28","author":"Hanieh","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153596","article-title":"Deciphering the roles of aryl hydrocarbon receptor (AHR) in regulating carcinogenesis","volume":"495","author":"Chong","year":"2023","journal-title":"Toxicology"},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.884004","article-title":"Aryl hydrocarbon receptor: from homeostasis to tumor progression","volume":"10","author":"Rejano-Gordillo","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jcp.22722","article-title":"Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway","volume":"227","author":"Zhang","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"29","key":"10.1016\/j.ijbiomac.2024.136921_bb0340","article-title":"FOXM1 inhibition enhances the therapeutic outcome of lung Cancer immunotherapy by modulating PD-L1 expression and cell proliferation","volume":"9","author":"Madhi","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136921_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020428","article-title":"Epithelial to mesenchymal transition: a mechanism that fuels Cancer radio\/Chemoresistance","volume":"9","author":"Dudas","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13046-020-01618-7","article-title":"3,3\u2019-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA\/ROCK1-mediated COX2\/PGE(2) pathway","volume":"39","author":"Zhu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2019.02.018","article-title":"Towards the first targeted therapy for triple-negative breast cancer: repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor","volume":"449","author":"Ahmed","year":"2019","journal-title":"Cancer Lett."},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.136921_bb0360","doi-asserted-by":"crossref","first-page":"38276","DOI":"10.18632\/oncotarget.11299","article-title":"Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma","volume":"8","author":"Zaccagnino","year":"2017","journal-title":"Oncotarget"},{"issue":"43","key":"10.1016\/j.ijbiomac.2024.136921_bb0365","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1038\/onc.2013.440","article-title":"A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer","volume":"33","author":"Luis-Ravelo","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/1541-7786.MCR-13-0136","article-title":"miR-335 inhibits small cell lung cancer bone metastases via IGF-IR and RANKL pathways","volume":"12","author":"Gong","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fendo.2017.00049","article-title":"CCL2\/monocyte chemoattractant protein 1 and parathyroid hormone action on bone","volume":"8","author":"Siddiqui","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136921_bb0380","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5312\/wjo.v3.i11.175","article-title":"New roles of osteoblasts involved in osteoclast differentiation","volume":"3","author":"Yamashita","year":"2012","journal-title":"World J. Orthop."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136921_bb0385","doi-asserted-by":"crossref","first-page":"8092","DOI":"10.1038\/s41467-023-44000-9","article-title":"Functional and analytical recapitulation of osteoclast biology on demineralized bone paper","volume":"14","author":"Park","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136921_bb0390","first-page":"233","article-title":"Physiological bone remodeling: systemic regulation and growth factor involvement","volume":"31","author":"Siddiqui","year":"2016","journal-title":"Physiology (Bethesda)"},{"issue":"21","key":"10.1016\/j.ijbiomac.2024.136921_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217931","article-title":"Kynurenine promotes RANKL-induced Osteoclastogenesis in vitro by activating the aryl hydrocarbon receptor pathway","volume":"21","author":"Eisa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136921_bb0400","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5483\/BMBRep.2017.50.3.223","article-title":"Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways","volume":"50","author":"Ihn","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0405","unstructured":"J.A. Siddiqui, G. Swarnkar, K. Sharan, B. Chakravarti, G. Sharma, P. Rawat, M. Kumar, F.M. Khan, D. Pierroz, R. Maurya, N. Chattopadhyay, 8,8\u201d-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8\u2033-biapigeninyl in ovariectomized mice, Mol. Cell. Endocrinol. 323(2) (2010) 256\u201367."},{"key":"10.1016\/j.ijbiomac.2024.136921_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110818","article-title":"Kynurenine suppresses osteoblastic cell energetics in vitro and osteoblast numbers in vivo","volume":"130","author":"Pierce","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136921_bb0415","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00198-014-2720-7","article-title":"Interferon gamma (IFN-gamma)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland health study","volume":"25","author":"Apalset","year":"2014","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136921_bb0420","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/cei.12288","article-title":"Interferon (IFN)-gamma-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland health study","volume":"176","author":"Apalset","year":"2014","journal-title":"Clin. Exp. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024077304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024077304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:47:18Z","timestamp":1782899238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024077304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":84,"alternative-id":["S0141813024077304"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136921","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clofazimine inhibits small-cell lung cancer progression by modulating the kynurenine\/aryl hydrocarbon receptor axis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"136921"}}